Agenus to Webcast Annual Meeting of Stockholders
June 08 2016 - 8:50AM
Business Wire
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company
developing antibodies including checkpoint inhibitors and other
checkpoint modulators, and cancer vaccines, invites investors
and the general public to its Annual Meeting of Stockholders to
begin at 5:00 p.m. ET on Tuesday, June 14, 2016. The meeting will
be held at the Company’s headquarters located at 3 Forbes Road,
Lexington, MA 02421. Registration for attendees starts at 4:30 p.m.
ET.
Webcast Information
A live webcast will be accessible from the Company’s website at
www.agenusbio.com/webcast. The archived replay will be available on
the Agenus website for at least 30 days following the meeting.
About Agenus
Agenus is an immuno-oncology company focused on the discovery
and development of revolutionary new treatments that engage the
body’s immune system to benefit patients suffering from cancer. By
combining multiple powerful platforms, Agenus has established a
highly integrated approach for the discovery, development and
manufacture of monoclonal antibodies that modulate targets of
interest. In addition, the Company’s cancer vaccine program
includes three proprietary platforms focused on individualized and
off-the-shelf vaccines uniquely designed for each patient. Agenus’
broad portfolio of novel checkpoint and other immuno-modulatory
monoclonal antibodies, vaccines and adjuvants, work in combination
to provide the opportunity to create best-in-class therapeutic
regimens. The Company has formed collaborations with Merck and
Incyte to discover and develop multiple checkpoint antibodies. For
more information, please visit www.agenusbio.com; information that
may be important to investors will be routinely posted on our
website.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160608005298/en/
Agenus Inc.Michelle Linn,
781-674-4541michelle.linn@agenusbio.com
Agenus (NASDAQ:AGEN)
Historical Stock Chart
From Jul 2024 to Aug 2024
Agenus (NASDAQ:AGEN)
Historical Stock Chart
From Aug 2023 to Aug 2024